Christopher J Evans

Title: Christopher J Evans: Innovator in Opioid Receptor Research

Introduction

Christopher J Evans is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of biomedical research, particularly in the area of opioid receptors. With a total of 6 patents to his name, Evans has established himself as a key figure in the scientific community.

Latest Patents

Evans' latest patents include groundbreaking work on DNA molecules encoding opioid receptors and methods of use thereof. This patent describes recombinant forms of isolated and purified delta opioid receptors and methods to screen for compounds that interact with these receptors. Another notable patent is for a system for protease-mediated protein expression. This invention provides methods and materials that can be used to detect, examine, and exploit protease-mediated protein expression. An illustrative embodiment of this invention includes a polynucleotide encoding a polypeptide with a degradation signal that functions as a proteasome substrate, along with a polypeptide of interest and a linker that comprises a protease recognition motif.

Career Highlights

Evans is affiliated with the University of California, where he continues to advance his research and innovation in the field. His work has garnered attention for its potential applications in medicine and biotechnology.

Collaborations

Throughout his career, Evans has collaborated with notable colleagues, including Duane E Keith, Jr and Robert H Edwards. These collaborations have further enriched his research and contributed to the development of innovative solutions in his field.

Conclusion

Christopher J Evans is a distinguished inventor whose work in opioid receptor research and protease-mediated protein expression has made a significant impact. His contributions continue to shape the landscape of biomedical research and innovation.